Sample calculations for comparison.
(a) $72m raised pre-efficacy at 10% discount to current share price 0.80, ie issue price is 0.72. Mkt cap post-efficacy is $5bn. New share price = 5bn/(2*115m) = 21.74,
(b) $72m raised post-efficacy at 10% discount to then share price, after which mkt cap is $5bn. [ie an apples-apples comparison). Share price pre-raising is (5bn-72m)-115m = 42.83. So IPO is of 72/(42.83*0.9)= 1.87m new shares. New share price = 5bn/(115m+1.87m)=42.80.
Now do you fully understand what I have been saying ... I have a distinct preference for my BLT shares being worth 42.80 rather than 21.74. (The number of shares in my holding doesn't change).
- Forums
- ASX - By Stock
- BLT
- Halelujah! We broke 80 cents!
Halelujah! We broke 80 cents!, page-16
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online